nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—CYP2C19—Methazolamide—glaucoma	0.0418	0.541	CbGbCtD
Famotidine—CYP2C19—Timolol—glaucoma	0.0356	0.46	CbGbCtD
Famotidine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.00195	0.0569	CbGpPWpGaD
Famotidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.00162	0.0471	CbGpPWpGaD
Famotidine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	0.00143	0.0416	CbGpPWpGaD
Famotidine—SLC22A2—Amine compound SLC transporters—SLC6A13—glaucoma	0.00135	0.0395	CbGpPWpGaD
Famotidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.00118	0.0345	CbGpPWpGaD
Famotidine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00111	0.0323	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.0011	0.0321	CbGpPWpGaD
Famotidine—SLC22A2—Neurotransmitter Release Cycle—SLC6A13—glaucoma	0.00103	0.0302	CbGpPWpGaD
Famotidine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00101	0.0294	CbGpPWpGaD
Famotidine—SLC22A2—Amine compound SLC transporters—SLC6A1—glaucoma	0.000991	0.0289	CbGpPWpGaD
Famotidine—Anorexia—Pilocarpine—glaucoma	0.000829	0.000933	CcSEcCtD
Famotidine—SLC47A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000828	0.0241	CbGpPWpGaD
Famotidine—Feeling abnormal—Acetazolamide—glaucoma	0.000827	0.000931	CcSEcCtD
Famotidine—Hypersensitivity—Apraclonidine—glaucoma	0.000827	0.000931	CcSEcCtD
Famotidine—Paraesthesia—Dorzolamide—glaucoma	0.000826	0.00093	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000824	0.000928	CcSEcCtD
Famotidine—Pain—Brimonidine—glaucoma	0.000824	0.000927	CcSEcCtD
Famotidine—Insomnia—Brinzolamide—glaucoma	0.000818	0.000921	CcSEcCtD
Famotidine—Somnolence—Dorzolamide—glaucoma	0.000818	0.000921	CcSEcCtD
Famotidine—Muscle spasms—Clonidine—glaucoma	0.000818	0.000921	CcSEcCtD
Famotidine—Paraesthesia—Brinzolamide—glaucoma	0.000812	0.000914	CcSEcCtD
Famotidine—Dysuria—Timolol—glaucoma	0.000812	0.000914	CcSEcCtD
Famotidine—Dyspepsia—Dorzolamide—glaucoma	0.00081	0.000912	CcSEcCtD
Famotidine—Upper respiratory tract infection—Timolol—glaucoma	0.000807	0.000908	CcSEcCtD
Famotidine—Dyspepsia—Travoprost—glaucoma	0.000806	0.000908	CcSEcCtD
Famotidine—Asthenia—Apraclonidine—glaucoma	0.000805	0.000906	CcSEcCtD
Famotidine—Somnolence—Brinzolamide—glaucoma	0.000804	0.000905	CcSEcCtD
Famotidine—Decreased appetite—Dorzolamide—glaucoma	0.0008	0.0009	CcSEcCtD
Famotidine—Erectile dysfunction—Timolol—glaucoma	0.0008	0.0009	CcSEcCtD
Famotidine—Urticaria—Acetazolamide—glaucoma	0.000797	0.000898	CcSEcCtD
Famotidine—Dyspepsia—Brinzolamide—glaucoma	0.000796	0.000896	CcSEcCtD
Famotidine—Pruritus—Apraclonidine—glaucoma	0.000794	0.000894	CcSEcCtD
Famotidine—Body temperature increased—Acetazolamide—glaucoma	0.000793	0.000893	CcSEcCtD
Famotidine—Fatigue—Dorzolamide—glaucoma	0.000793	0.000893	CcSEcCtD
Famotidine—Tinnitus—Betaxolol—glaucoma	0.000793	0.000893	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000792	0.000892	CcSEcCtD
Famotidine—Fatigue—Travoprost—glaucoma	0.00079	0.000889	CcSEcCtD
Famotidine—Flushing—Betaxolol—glaucoma	0.00079	0.000889	CcSEcCtD
Famotidine—Pain—Dorzolamide—glaucoma	0.000787	0.000886	CcSEcCtD
Famotidine—Insomnia—Pilocarpine—glaucoma	0.000786	0.000885	CcSEcCtD
Famotidine—Decreased appetite—Brinzolamide—glaucoma	0.000786	0.000885	CcSEcCtD
Famotidine—Pain—Travoprost—glaucoma	0.000783	0.000882	CcSEcCtD
Famotidine—Constipation—Travoprost—glaucoma	0.000783	0.000882	CcSEcCtD
Famotidine—Agitation—Clonidine—glaucoma	0.000782	0.00088	CcSEcCtD
Famotidine—Paraesthesia—Pilocarpine—glaucoma	0.000781	0.000879	CcSEcCtD
Famotidine—Asthenia—Bimatoprost—glaucoma	0.000781	0.000879	CcSEcCtD
Famotidine—Fatigue—Brinzolamide—glaucoma	0.00078	0.000878	CcSEcCtD
Famotidine—Angioedema—Clonidine—glaucoma	0.000777	0.000875	CcSEcCtD
Famotidine—Pain—Brinzolamide—glaucoma	0.000773	0.000871	CcSEcCtD
Famotidine—Somnolence—Pilocarpine—glaucoma	0.000773	0.00087	CcSEcCtD
Famotidine—Depression—Timolol—glaucoma	0.000772	0.000869	CcSEcCtD
Famotidine—Pruritus—Bimatoprost—glaucoma	0.00077	0.000866	CcSEcCtD
Famotidine—Diarrhoea—Apraclonidine—glaucoma	0.000768	0.000864	CcSEcCtD
Famotidine—Dyspepsia—Pilocarpine—glaucoma	0.000765	0.000861	CcSEcCtD
Famotidine—Syncope—Clonidine—glaucoma	0.000763	0.000859	CcSEcCtD
Famotidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000761	0.0222	CbGpPWpGaD
Famotidine—Arrhythmia—Betaxolol—glaucoma	0.00076	0.000855	CcSEcCtD
Famotidine—Feeling abnormal—Dorzolamide—glaucoma	0.000758	0.000853	CcSEcCtD
Famotidine—SLC22A2—Neurotransmitter Release Cycle—SLC6A1—glaucoma	0.000757	0.0221	CbGpPWpGaD
Famotidine—Decreased appetite—Pilocarpine—glaucoma	0.000756	0.000851	CcSEcCtD
Famotidine—Feeling abnormal—Travoprost—glaucoma	0.000755	0.00085	CcSEcCtD
Famotidine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000752	0.000847	CcSEcCtD
Famotidine—Alopecia—Betaxolol—glaucoma	0.000752	0.000846	CcSEcCtD
Famotidine—Palpitations—Clonidine—glaucoma	0.000752	0.000846	CcSEcCtD
Famotidine—Gastrointestinal pain—Travoprost—glaucoma	0.000749	0.000843	CcSEcCtD
Famotidine—Loss of consciousness—Clonidine—glaucoma	0.000748	0.000842	CcSEcCtD
Famotidine—Feeling abnormal—Brinzolamide—glaucoma	0.000745	0.000839	CcSEcCtD
Famotidine—Mental disorder—Betaxolol—glaucoma	0.000745	0.000839	CcSEcCtD
Famotidine—Constipation—Pilocarpine—glaucoma	0.000743	0.000837	CcSEcCtD
Famotidine—Pain—Pilocarpine—glaucoma	0.000743	0.000837	CcSEcCtD
Famotidine—Cough—Clonidine—glaucoma	0.000742	0.000836	CcSEcCtD
Famotidine—Dizziness—Apraclonidine—glaucoma	0.000742	0.000835	CcSEcCtD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000734	0.0214	CbGpPWpGaD
Famotidine—Urticaria—Dorzolamide—glaucoma	0.000731	0.000823	CcSEcCtD
Famotidine—Body temperature increased—Dorzolamide—glaucoma	0.000727	0.000819	CcSEcCtD
Famotidine—Abdominal pain—Dorzolamide—glaucoma	0.000727	0.000819	CcSEcCtD
Famotidine—Sinusitis—Timolol—glaucoma	0.000726	0.000818	CcSEcCtD
Famotidine—Dysgeusia—Betaxolol—glaucoma	0.000725	0.000816	CcSEcCtD
Famotidine—Chest pain—Clonidine—glaucoma	0.000724	0.000815	CcSEcCtD
Famotidine—Arthralgia—Clonidine—glaucoma	0.000724	0.000815	CcSEcCtD
Famotidine—Abdominal pain—Travoprost—glaucoma	0.000724	0.000815	CcSEcCtD
Famotidine—Agranulocytosis—Timolol—glaucoma	0.000722	0.000813	CcSEcCtD
Famotidine—Anxiety—Clonidine—glaucoma	0.000722	0.000812	CcSEcCtD
Famotidine—Asthenia—Acetazolamide—glaucoma	0.00072	0.000811	CcSEcCtD
Famotidine—Dizziness—Bimatoprost—glaucoma	0.000719	0.00081	CcSEcCtD
Famotidine—Urticaria—Brinzolamide—glaucoma	0.000719	0.000809	CcSEcCtD
Famotidine—Feeling abnormal—Pilocarpine—glaucoma	0.000716	0.000806	CcSEcCtD
Famotidine—Vomiting—Apraclonidine—glaucoma	0.000713	0.000803	CcSEcCtD
Famotidine—Muscle spasms—Betaxolol—glaucoma	0.000712	0.000801	CcSEcCtD
Famotidine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000711	0.0008	CcSEcCtD
Famotidine—Hypersensitivity—Brimonidine—glaucoma	0.00071	0.000799	CcSEcCtD
Famotidine—Dry mouth—Clonidine—glaucoma	0.000708	0.000797	CcSEcCtD
Famotidine—Bradycardia—Timolol—glaucoma	0.000707	0.000796	CcSEcCtD
Famotidine—Dermatitis—Apraclonidine—glaucoma	0.000707	0.000796	CcSEcCtD
Famotidine—Headache—Apraclonidine—glaucoma	0.000703	0.000791	CcSEcCtD
Famotidine—Confusional state—Clonidine—glaucoma	0.0007	0.000788	CcSEcCtD
Famotidine—Oedema—Clonidine—glaucoma	0.000694	0.000781	CcSEcCtD
Famotidine—Hallucination—Timolol—glaucoma	0.000691	0.000778	CcSEcCtD
Famotidine—Asthenia—Brimonidine—glaucoma	0.000691	0.000778	CcSEcCtD
Famotidine—Infection—Clonidine—glaucoma	0.00069	0.000776	CcSEcCtD
Famotidine—Body temperature increased—Pilocarpine—glaucoma	0.000687	0.000774	CcSEcCtD
Famotidine—Abdominal pain—Pilocarpine—glaucoma	0.000687	0.000774	CcSEcCtD
Famotidine—Diarrhoea—Acetazolamide—glaucoma	0.000687	0.000773	CcSEcCtD
Famotidine—Rash—Bimatoprost—glaucoma	0.000686	0.000772	CcSEcCtD
Famotidine—Dermatitis—Bimatoprost—glaucoma	0.000685	0.000771	CcSEcCtD
Famotidine—Anaemia—Betaxolol—glaucoma	0.000684	0.00077	CcSEcCtD
Famotidine—Shock—Clonidine—glaucoma	0.000683	0.000769	CcSEcCtD
Famotidine—Pruritus—Brimonidine—glaucoma	0.000682	0.000767	CcSEcCtD
Famotidine—Headache—Bimatoprost—glaucoma	0.000682	0.000767	CcSEcCtD
Famotidine—Thrombocytopenia—Clonidine—glaucoma	0.00068	0.000765	CcSEcCtD
Famotidine—Hypersensitivity—Dorzolamide—glaucoma	0.000678	0.000763	CcSEcCtD
Famotidine—Hypersensitivity—Travoprost—glaucoma	0.000675	0.00076	CcSEcCtD
Famotidine—Nausea—Apraclonidine—glaucoma	0.000666	0.00075	CcSEcCtD
Famotidine—Hypersensitivity—Brinzolamide—glaucoma	0.000666	0.00075	CcSEcCtD
Famotidine—Syncope—Betaxolol—glaucoma	0.000664	0.000748	CcSEcCtD
Famotidine—Dizziness—Acetazolamide—glaucoma	0.000664	0.000747	CcSEcCtD
Famotidine—Anorexia—Clonidine—glaucoma	0.000662	0.000745	CcSEcCtD
Famotidine—Asthenia—Dorzolamide—glaucoma	0.00066	0.000743	CcSEcCtD
Famotidine—Asthenia—Travoprost—glaucoma	0.000657	0.00074	CcSEcCtD
Famotidine—Palpitations—Betaxolol—glaucoma	0.000654	0.000737	CcSEcCtD
Famotidine—Pruritus—Dorzolamide—glaucoma	0.000651	0.000733	CcSEcCtD
Famotidine—Loss of consciousness—Betaxolol—glaucoma	0.000651	0.000733	CcSEcCtD
Famotidine—Asthenia—Brinzolamide—glaucoma	0.000649	0.00073	CcSEcCtD
Famotidine—Pruritus—Travoprost—glaucoma	0.000648	0.00073	CcSEcCtD
Famotidine—Tinnitus—Timolol—glaucoma	0.000648	0.000729	CcSEcCtD
Famotidine—Cough—Betaxolol—glaucoma	0.000646	0.000727	CcSEcCtD
Famotidine—Nausea—Bimatoprost—glaucoma	0.000646	0.000727	CcSEcCtD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000643	0.0187	CbGpPWpGaD
Famotidine—Hypersensitivity—Pilocarpine—glaucoma	0.00064	0.000721	CcSEcCtD
Famotidine—Pruritus—Brinzolamide—glaucoma	0.00064	0.00072	CcSEcCtD
Famotidine—Vomiting—Acetazolamide—glaucoma	0.000638	0.000718	CcSEcCtD
Famotidine—Dizziness—Brimonidine—glaucoma	0.000637	0.000717	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000632	0.000712	CcSEcCtD
Famotidine—Myalgia—Betaxolol—glaucoma	0.00063	0.00071	CcSEcCtD
Famotidine—Arthralgia—Betaxolol—glaucoma	0.00063	0.00071	CcSEcCtD
Famotidine—Chest pain—Betaxolol—glaucoma	0.00063	0.00071	CcSEcCtD
Famotidine—Diarrhoea—Dorzolamide—glaucoma	0.000629	0.000709	CcSEcCtD
Famotidine—Headache—Acetazolamide—glaucoma	0.000629	0.000708	CcSEcCtD
Famotidine—Anxiety—Betaxolol—glaucoma	0.000628	0.000707	CcSEcCtD
Famotidine—Insomnia—Clonidine—glaucoma	0.000628	0.000707	CcSEcCtD
Famotidine—Diarrhoea—Travoprost—glaucoma	0.000627	0.000706	CcSEcCtD
Famotidine—Asthenia—Pilocarpine—glaucoma	0.000624	0.000702	CcSEcCtD
Famotidine—Paraesthesia—Clonidine—glaucoma	0.000623	0.000702	CcSEcCtD
Famotidine—Arrhythmia—Timolol—glaucoma	0.000621	0.000699	CcSEcCtD
Famotidine—Diarrhoea—Brinzolamide—glaucoma	0.000619	0.000697	CcSEcCtD
Famotidine—Somnolence—Clonidine—glaucoma	0.000617	0.000695	CcSEcCtD
Famotidine—Dry mouth—Betaxolol—glaucoma	0.000617	0.000694	CcSEcCtD
Famotidine—Pruritus—Pilocarpine—glaucoma	0.000615	0.000692	CcSEcCtD
Famotidine—Alopecia—Timolol—glaucoma	0.000614	0.000691	CcSEcCtD
Famotidine—Confusional state—Betaxolol—glaucoma	0.000609	0.000686	CcSEcCtD
Famotidine—Mental disorder—Timolol—glaucoma	0.000609	0.000685	CcSEcCtD
Famotidine—Dizziness—Dorzolamide—glaucoma	0.000608	0.000685	CcSEcCtD
Famotidine—Rash—Brimonidine—glaucoma	0.000607	0.000684	CcSEcCtD
Famotidine—Dermatitis—Brimonidine—glaucoma	0.000607	0.000683	CcSEcCtD
Famotidine—Dizziness—Travoprost—glaucoma	0.000606	0.000682	CcSEcCtD
Famotidine—Oedema—Betaxolol—glaucoma	0.000604	0.00068	CcSEcCtD
Famotidine—Headache—Brimonidine—glaucoma	0.000603	0.000679	CcSEcCtD
Famotidine—Decreased appetite—Clonidine—glaucoma	0.000603	0.000679	CcSEcCtD
Famotidine—Infection—Betaxolol—glaucoma	0.0006	0.000676	CcSEcCtD
Famotidine—Fatigue—Clonidine—glaucoma	0.000599	0.000674	CcSEcCtD
Famotidine—Dizziness—Brinzolamide—glaucoma	0.000598	0.000673	CcSEcCtD
Famotidine—Nausea—Acetazolamide—glaucoma	0.000596	0.000671	CcSEcCtD
Famotidine—Diarrhoea—Pilocarpine—glaucoma	0.000595	0.00067	CcSEcCtD
Famotidine—Shock—Betaxolol—glaucoma	0.000595	0.000669	CcSEcCtD
Famotidine—Constipation—Clonidine—glaucoma	0.000594	0.000668	CcSEcCtD
Famotidine—Pain—Clonidine—glaucoma	0.000594	0.000668	CcSEcCtD
Famotidine—Dysgeusia—Timolol—glaucoma	0.000592	0.000667	CcSEcCtD
Famotidine—Thrombocytopenia—Betaxolol—glaucoma	0.000592	0.000666	CcSEcCtD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000588	0.0171	CbGpPWpGaD
Famotidine—Vomiting—Dorzolamide—glaucoma	0.000585	0.000658	CcSEcCtD
Famotidine—Rash—Dorzolamide—glaucoma	0.00058	0.000653	CcSEcCtD
Famotidine—Dermatitis—Dorzolamide—glaucoma	0.00058	0.000652	CcSEcCtD
Famotidine—Rash—Travoprost—glaucoma	0.000578	0.00065	CcSEcCtD
Famotidine—Dermatitis—Travoprost—glaucoma	0.000577	0.00065	CcSEcCtD
Famotidine—Headache—Dorzolamide—glaucoma	0.000576	0.000649	CcSEcCtD
Famotidine—Anorexia—Betaxolol—glaucoma	0.000576	0.000649	CcSEcCtD
Famotidine—Vomiting—Brinzolamide—glaucoma	0.000575	0.000647	CcSEcCtD
Famotidine—Dizziness—Pilocarpine—glaucoma	0.000575	0.000647	CcSEcCtD
Famotidine—Headache—Travoprost—glaucoma	0.000574	0.000646	CcSEcCtD
Famotidine—Nausea—Brimonidine—glaucoma	0.000572	0.000644	CcSEcCtD
Famotidine—Feeling abnormal—Clonidine—glaucoma	0.000572	0.000644	CcSEcCtD
Famotidine—Rash—Brinzolamide—glaucoma	0.00057	0.000642	CcSEcCtD
Famotidine—Dermatitis—Brinzolamide—glaucoma	0.00057	0.000641	CcSEcCtD
Famotidine—Gastrointestinal pain—Clonidine—glaucoma	0.000568	0.000639	CcSEcCtD
Famotidine—Headache—Brinzolamide—glaucoma	0.000567	0.000638	CcSEcCtD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000559	0.0163	CbGpPWpGaD
Famotidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000557	0.0162	CbGpPWpGaD
Famotidine—Angioedema—Timolol—glaucoma	0.000553	0.000622	CcSEcCtD
Famotidine—Vomiting—Pilocarpine—glaucoma	0.000553	0.000622	CcSEcCtD
Famotidine—Urticaria—Clonidine—glaucoma	0.000551	0.000621	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000551	0.00062	CcSEcCtD
Famotidine—Abdominal pain—Clonidine—glaucoma	0.000549	0.000618	CcSEcCtD
Famotidine—Body temperature increased—Clonidine—glaucoma	0.000549	0.000618	CcSEcCtD
Famotidine—Rash—Pilocarpine—glaucoma	0.000548	0.000617	CcSEcCtD
Famotidine—Dermatitis—Pilocarpine—glaucoma	0.000548	0.000616	CcSEcCtD
Famotidine—Insomnia—Betaxolol—glaucoma	0.000547	0.000615	CcSEcCtD
Famotidine—Nausea—Dorzolamide—glaucoma	0.000546	0.000615	CcSEcCtD
Famotidine—Headache—Pilocarpine—glaucoma	0.000545	0.000613	CcSEcCtD
Famotidine—Nausea—Travoprost—glaucoma	0.000544	0.000612	CcSEcCtD
Famotidine—Paraesthesia—Betaxolol—glaucoma	0.000543	0.000611	CcSEcCtD
Famotidine—Syncope—Timolol—glaucoma	0.000543	0.000611	CcSEcCtD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000537	0.0157	CbGpPWpGaD
Famotidine—Nausea—Brinzolamide—glaucoma	0.000537	0.000605	CcSEcCtD
Famotidine—Palpitations—Timolol—glaucoma	0.000535	0.000602	CcSEcCtD
Famotidine—Dyspepsia—Betaxolol—glaucoma	0.000532	0.000599	CcSEcCtD
Famotidine—Loss of consciousness—Timolol—glaucoma	0.000532	0.000599	CcSEcCtD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.00053	0.0154	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000529	0.0154	CbGpPWpGaD
Famotidine—Cough—Timolol—glaucoma	0.000528	0.000594	CcSEcCtD
Famotidine—Decreased appetite—Betaxolol—glaucoma	0.000525	0.000591	CcSEcCtD
Famotidine—Fatigue—Betaxolol—glaucoma	0.000521	0.000587	CcSEcCtD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000518	0.0151	CbGpPWpGaD
Famotidine—Pain—Betaxolol—glaucoma	0.000517	0.000582	CcSEcCtD
Famotidine—Constipation—Betaxolol—glaucoma	0.000517	0.000582	CcSEcCtD
Famotidine—Nausea—Pilocarpine—glaucoma	0.000516	0.000581	CcSEcCtD
Famotidine—Arthralgia—Timolol—glaucoma	0.000515	0.00058	CcSEcCtD
Famotidine—Chest pain—Timolol—glaucoma	0.000515	0.00058	CcSEcCtD
Famotidine—Myalgia—Timolol—glaucoma	0.000515	0.00058	CcSEcCtD
Famotidine—Anxiety—Timolol—glaucoma	0.000513	0.000578	CcSEcCtD
Famotidine—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	0.000512	0.0149	CbGpPWpGaD
Famotidine—Hypersensitivity—Clonidine—glaucoma	0.000511	0.000576	CcSEcCtD
Famotidine—Dry mouth—Timolol—glaucoma	0.000504	0.000567	CcSEcCtD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000504	0.0147	CbGpPWpGaD
Famotidine—Asthenia—Clonidine—glaucoma	0.000498	0.000561	CcSEcCtD
Famotidine—Feeling abnormal—Betaxolol—glaucoma	0.000498	0.000561	CcSEcCtD
Famotidine—Confusional state—Timolol—glaucoma	0.000498	0.00056	CcSEcCtD
Famotidine—Oedema—Timolol—glaucoma	0.000494	0.000556	CcSEcCtD
Famotidine—Anaphylactic shock—Timolol—glaucoma	0.000494	0.000556	CcSEcCtD
Famotidine—Pruritus—Clonidine—glaucoma	0.000491	0.000553	CcSEcCtD
Famotidine—Infection—Timolol—glaucoma	0.000491	0.000552	CcSEcCtD
Famotidine—Shock—Timolol—glaucoma	0.000486	0.000547	CcSEcCtD
Famotidine—Urticaria—Betaxolol—glaucoma	0.00048	0.00054	CcSEcCtD
Famotidine—Body temperature increased—Betaxolol—glaucoma	0.000478	0.000538	CcSEcCtD
Famotidine—Diarrhoea—Clonidine—glaucoma	0.000475	0.000535	CcSEcCtD
Famotidine—Anorexia—Timolol—glaucoma	0.000471	0.00053	CcSEcCtD
Famotidine—Dizziness—Clonidine—glaucoma	0.000459	0.000517	CcSEcCtD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000453	0.0132	CbGpPWpGaD
Famotidine—Musculoskeletal discomfort—Timolol—glaucoma	0.00045	0.000506	CcSEcCtD
Famotidine—Insomnia—Timolol—glaucoma	0.000447	0.000503	CcSEcCtD
Famotidine—Hypersensitivity—Betaxolol—glaucoma	0.000445	0.000501	CcSEcCtD
Famotidine—Paraesthesia—Timolol—glaucoma	0.000443	0.000499	CcSEcCtD
Famotidine—Vomiting—Clonidine—glaucoma	0.000441	0.000497	CcSEcCtD
Famotidine—Somnolence—Timolol—glaucoma	0.000439	0.000494	CcSEcCtD
Famotidine—Rash—Clonidine—glaucoma	0.000438	0.000493	CcSEcCtD
Famotidine—Dermatitis—Clonidine—glaucoma	0.000437	0.000492	CcSEcCtD
Famotidine—Headache—Clonidine—glaucoma	0.000435	0.00049	CcSEcCtD
Famotidine—Dyspepsia—Timolol—glaucoma	0.000435	0.000489	CcSEcCtD
Famotidine—Asthenia—Betaxolol—glaucoma	0.000434	0.000488	CcSEcCtD
Famotidine—Decreased appetite—Timolol—glaucoma	0.000429	0.000483	CcSEcCtD
Famotidine—Pruritus—Betaxolol—glaucoma	0.000428	0.000481	CcSEcCtD
Famotidine—Fatigue—Timolol—glaucoma	0.000426	0.000479	CcSEcCtD
Famotidine—Pain—Timolol—glaucoma	0.000422	0.000475	CcSEcCtD
Famotidine—Diarrhoea—Betaxolol—glaucoma	0.000414	0.000466	CcSEcCtD
Famotidine—Nausea—Clonidine—glaucoma	0.000412	0.000464	CcSEcCtD
Famotidine—Feeling abnormal—Timolol—glaucoma	0.000407	0.000458	CcSEcCtD
Famotidine—Gastrointestinal pain—Timolol—glaucoma	0.000404	0.000454	CcSEcCtD
Famotidine—Dizziness—Betaxolol—glaucoma	0.0004	0.00045	CcSEcCtD
Famotidine—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000395	0.0115	CbGpPWpGaD
Famotidine—Urticaria—Timolol—glaucoma	0.000392	0.000442	CcSEcCtD
Famotidine—Abdominal pain—Timolol—glaucoma	0.00039	0.000439	CcSEcCtD
Famotidine—Body temperature increased—Timolol—glaucoma	0.00039	0.000439	CcSEcCtD
Famotidine—SLC22A8—Transmembrane transport of small molecules—PEX19—glaucoma	0.00039	0.0114	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000388	0.0113	CbGpPWpGaD
Famotidine—Vomiting—Betaxolol—glaucoma	0.000384	0.000433	CcSEcCtD
Famotidine—HRH2—GPCR ligand binding—OPN4—glaucoma	0.000383	0.0112	CbGpPWpGaD
Famotidine—Rash—Betaxolol—glaucoma	0.000381	0.000429	CcSEcCtD
Famotidine—Dermatitis—Betaxolol—glaucoma	0.000381	0.000429	CcSEcCtD
Famotidine—Headache—Betaxolol—glaucoma	0.000379	0.000426	CcSEcCtD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000373	0.0109	CbGpPWpGaD
Famotidine—Hypersensitivity—Timolol—glaucoma	0.000364	0.000409	CcSEcCtD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000361	0.0105	CbGpPWpGaD
Famotidine—Nausea—Betaxolol—glaucoma	0.000359	0.000404	CcSEcCtD
Famotidine—Asthenia—Timolol—glaucoma	0.000354	0.000399	CcSEcCtD
Famotidine—Pruritus—Timolol—glaucoma	0.000349	0.000393	CcSEcCtD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000346	0.0101	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—PTGFR—glaucoma	0.000345	0.0101	CbGpPWpGaD
Famotidine—Diarrhoea—Timolol—glaucoma	0.000338	0.00038	CcSEcCtD
Famotidine—Dizziness—Timolol—glaucoma	0.000327	0.000368	CcSEcCtD
Famotidine—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.00032	0.00932	CbGpPWpGaD
Famotidine—Vomiting—Timolol—glaucoma	0.000314	0.000353	CcSEcCtD
Famotidine—Rash—Timolol—glaucoma	0.000311	0.00035	CcSEcCtD
Famotidine—Dermatitis—Timolol—glaucoma	0.000311	0.00035	CcSEcCtD
Famotidine—Headache—Timolol—glaucoma	0.000309	0.000348	CcSEcCtD
Famotidine—SLC22A2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000297	0.00865	CbGpPWpGaD
Famotidine—Nausea—Timolol—glaucoma	0.000293	0.00033	CcSEcCtD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000273	0.00796	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000271	0.00791	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000263	0.00768	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.00026	0.00758	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000256	0.00745	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000253	0.00738	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000241	0.00702	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—SLC6A13—glaucoma	0.000227	0.00663	CbGpPWpGaD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000221	0.00644	CbGpPWpGaD
Famotidine—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000218	0.00635	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000217	0.00633	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—OPN4—glaucoma	0.000217	0.00632	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—OPN4—glaucoma	0.000197	0.00574	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PTGFR—glaucoma	0.000195	0.00569	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000183	0.00534	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000179	0.00522	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PTGFR—glaucoma	0.000177	0.00516	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000176	0.00513	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000176	0.00512	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—SMO—glaucoma	0.000174	0.00507	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LRP12—glaucoma	0.000168	0.00489	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—SLC6A1—glaucoma	0.000166	0.00485	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000151	0.00439	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CA5A—glaucoma	0.000149	0.00436	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NARFL—glaucoma	0.000149	0.00436	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000132	0.00384	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000129	0.00375	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000122	0.00356	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTT1—glaucoma	0.000119	0.00348	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—OPN4—glaucoma	0.000116	0.00339	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	0.000115	0.00336	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—EDN1—glaucoma	0.000115	0.00335	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HEYL—glaucoma	0.000108	0.00315	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PTGFR—glaucoma	0.000105	0.00305	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—C3—glaucoma	0.0001	0.00292	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP1B1—glaucoma	9.51e-05	0.00277	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	9.38e-05	0.00273	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.95e-05	0.00261	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—SMO—glaucoma	8.93e-05	0.0026	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.89e-05	0.00259	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NARFL—glaucoma	8.37e-05	0.00244	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CA5A—glaucoma	8.37e-05	0.00244	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RPTOR—glaucoma	8.19e-05	0.00239	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NCK2—glaucoma	7.93e-05	0.00231	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTM1—glaucoma	7.6e-05	0.00222	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	7.5e-05	0.00219	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CA1—glaucoma	7.3e-05	0.00213	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CTSA—glaucoma	7.07e-05	0.00206	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HDAC9—glaucoma	6.74e-05	0.00197	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CA2—glaucoma	6.68e-05	0.00195	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—EDN1—glaucoma	6.49e-05	0.00189	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EDN1—glaucoma	5.89e-05	0.00172	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—C3—glaucoma	5.67e-05	0.00165	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SMO—glaucoma	5.28e-05	0.00154	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—C3—glaucoma	5.15e-05	0.0015	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NTRK2—glaucoma	4.83e-05	0.00141	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TXN—glaucoma	4.7e-05	0.00137	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NGFR—glaucoma	4.14e-05	0.00121	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CA1—glaucoma	4.09e-05	0.00119	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CTSA—glaucoma	3.96e-05	0.00115	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NTRK1—glaucoma	3.93e-05	0.00115	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CA2—glaucoma	3.74e-05	0.00109	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.65e-05	0.00106	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.65e-05	0.00106	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTT1—glaucoma	3.65e-05	0.00106	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN2B—glaucoma	3.63e-05	0.00106	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EDN1—glaucoma	3.48e-05	0.00101	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NGF—glaucoma	3.2e-05	0.000932	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—C3—glaucoma	3.04e-05	0.000886	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP1B1—glaucoma	2.91e-05	0.000847	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCA1—glaucoma	2.91e-05	0.000847	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOE—glaucoma	2.83e-05	0.000825	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CAV1—glaucoma	2.8e-05	0.000817	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FN1—glaucoma	2.67e-05	0.000778	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—BAD—glaucoma	2.64e-05	0.000769	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TXN—glaucoma	2.63e-05	0.000767	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.4e-05	0.0007	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.38e-05	0.000694	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTM1—glaucoma	2.32e-05	0.000677	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOS3—glaucoma	2.12e-05	0.000618	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTHFR—glaucoma	2.05e-05	0.000598	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTT1—glaucoma	2.04e-05	0.000595	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOE—glaucoma	1.91e-05	0.000557	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CAV1—glaucoma	1.89e-05	0.000552	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CDKN1B—glaucoma	1.84e-05	0.000535	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MMP9—glaucoma	1.7e-05	0.000496	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.65e-05	0.00048	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP1B1—glaucoma	1.63e-05	0.000474	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCA1—glaucoma	1.63e-05	0.000474	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VEGFA—glaucoma	1.53e-05	0.000445	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NOS3—glaucoma	1.43e-05	0.000417	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—glaucoma	1.31e-05	0.000382	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTM1—glaucoma	1.3e-05	0.000379	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TP53—glaucoma	1.15e-05	0.000336	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTHFR—glaucoma	1.15e-05	0.000335	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOE—glaucoma	1.07e-05	0.000312	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CAV1—glaucoma	1.06e-05	0.000309	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NOS3—glaucoma	8.02e-06	0.000234	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—glaucoma	7.33e-06	0.000214	CbGpPWpGaD
